SCHEMBL9258255

SCHEMBL9258255

COC(=O)CCc1nc(-c2ccc(-c3ccc(C(=N)N)cc3)cc2)cs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
ITGB3 P05106 6/20 0.48
ITGA2B P08514 6/20 0.48
HDAC3 O15379 4/20 0.47
HDAC4 P56524 4/20 0.47
HDAC1 Q13547 4/20 0.47
HDAC7 Q8WUI4 4/20 0.47
HDAC2 Q92769 4/20 0.47
HDAC10 Q969S8 4/20 0.47
HDAC11 Q96DB2 4/20 0.47
HDAC8 Q9BY41 4/20 0.47
HDAC6 Q9UBN7 4/20 0.47
HDAC9 Q9UKV0 4/20 0.47
HDAC5 Q9UQL6 4/20 0.47
RAB9A P51151 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 2/20 0.45
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9253949 0.85 ITGB3 (0.52) MEN1ITGB3ITGA2BHDAC3HDAC4
SCHEMBL9257819 0.84 NPC1 (0.50) MEN1ITGB3ITGA2BRAB9AALDH1A1
Hydrochloric Acid SCHEMBL9254684 0.83 NPC1 (0.49) MEN1ITGB3ITGA2BRAB9AALDH1A1
SCHEMBL9253913 0.79 PRMT1 (0.53) L3MBTL1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL9258406 0.79 ITGB3 (0.55) MEN1ITGB3ITGA2BRAB9AALDH1A1
SCHEMBL9248073 0.78 GAA (0.43) MEN1ITGB3ITGA2BALDH1A1LMNA
SCHEMBL9254531 0.78 TMPRSS15 (0.43) ITGB3ITGA2BHDAC6MAPTSMN1; SMN2
SCHEMBL9251433 0.78 ITGB3 (0.42) MEN1ITGB3ITGA2BHDAC3HDAC4
SCHEMBL9252726 0.77 TMPRSS15 (0.38) ITGB3ITGA2BMAPTF2
SCHEMBL9254605 0.76 ITGB3 (0.41) ITGB3ITGA2BRAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463071-A Tetrazole derivatives; useful for inhibiting undesirable cell aggregation DR. KARL THOMAE GMBH (DE) 1995-10-31 US disclosed
EP-0525629-A2 5-membered heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-02-03 EP disclosed